Clinical Trials Logo

Filter by:
NCT ID: NCT00314288 Completed - Parkinson's Disease Clinical Trials

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Start date: July 2002
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship (dose-finding).

NCT ID: NCT00314210 Completed - Anxiety Disorders Clinical Trials

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

PLATINUM
Start date: March 2006
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of quetiapine SR compared to placebo in increasing time from randomisation to an anxiety event in patients with generalised anxiety disorder (GAD). PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00313170 Completed - Clinical trials for Metastatic Breast Cancer

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

FINDER II
Start date: May 30, 2006
Phase: Phase 2
Study type: Interventional

This study will assess the relationship between fulvestrant dose and efficacy in postmenopausal women with oestrogen receptor positive advanced breast cancer.

NCT ID: NCT00312845 Completed - Clinical trials for Non-Hodgkin's Lymphoma

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the combination of VELCADE and rituximab improves progression free survival relative to rituximab alone in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (B-NHL) who never received rituximab or who have previously responded to rituximab. This is an international study being conducted in the United States and in many countries around the world. A complete list of study locations is listed below.

NCT ID: NCT00312208 Completed - Breast Cancer Clinical Trials

Docetaxel in Breast Cancer

Start date: November 2001
Phase: Phase 3
Study type: Interventional

Primary objective : - To compare disease-free survival after treatment with docetaxel in combination with doxorubicin and cyclophosphamide to doxorubicin and cyclophosphamide followed by docetaxel in operable adjuvant breast cancer HER2neu negative patients with positive axillary lymph nodes. Secondary objectives : - To compare toxicity and quality of life between the 2 above-mentioned arms. - To evaluate pathologic and molecular markers for predicting efficacy.

NCT ID: NCT00312013 Completed - Thrombosis, Venous Clinical Trials

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Start date: May 2006
Phase: Phase 3
Study type: Interventional

This study will evaluate the effects of nadroparin on survival and disease progression in patients with hormone-refractory prostate cancer (HRPC), locally advanced pancreatic cancer or non-small-cell lung carcinoma (NSCLC).

NCT ID: NCT00311662 Completed - Clinical trials for Migraine Without Aura

Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

Start date: April 2006
Phase: Phase 2
Study type: Interventional

Overall trial objectives: - Can treatment with tonabersat reduce the number of days with a migraine headache in patients who suffer from frequent migraine attacks - How well tolerated is treatment with tonabersat The study is based on the hypothesis that the unique mechanism of action of tonabersat will inhibit some of the early events in the generation of migraine and so be effective as prophylactic treatment

NCT ID: NCT00310973 Completed - HIV Infections Clinical Trials

HIV Prevention Within High-Risk Bulgarian and Hungarian Social Networks

Start date: February 2003
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the effectiveness of peer-led HIV/sexually transmitted disease (STD)risk reduction educational counseling in reducing HIV risk behavior among the social networks of young men who have sex with men and Roma men and women in Bulgaria and Hungary.

NCT ID: NCT00307801 Completed - Metrorrhagia Clinical Trials

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.

NCT ID: NCT00306215 Completed - Crohn's Disease Clinical Trials

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

Start date: March 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether CCX282-B is effective in treating patients with moderate to severe Crohn's Disease.